Does IDURSULFASE Cause Mobility decreased? 35 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 35 reports of Mobility decreased have been filed in association with IDURSULFASE (ELAPRASE). This represents 1.1% of all adverse event reports for IDURSULFASE.
35
Reports of Mobility decreased with IDURSULFASE
1.1%
of all IDURSULFASE reports
6
Deaths
21
Hospitalizations
How Dangerous Is Mobility decreased From IDURSULFASE?
Of the 35 reports, 6 (17.1%) resulted in death, 21 (60.0%) required hospitalization, and 1 (2.9%) were considered life-threatening.
Is Mobility decreased Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for IDURSULFASE. However, 35 reports have been filed with the FAERS database.
What Other Side Effects Does IDURSULFASE Cause?
Pyrexia (524)
Product dose omission issue (450)
Inappropriate schedule of product administration (371)
Cough (263)
Infusion related reaction (241)
Pneumonia (232)
Death (222)
Dyspnoea (202)
Influenza (200)
Covid-19 (197)
What Other Drugs Cause Mobility decreased?
ADALIMUMAB (8,829)
ETANERCEPT (8,321)
METHOTREXATE (5,936)
ABATACEPT (4,519)
TOCILIZUMAB (4,403)
LEFLUNOMIDE (4,354)
HYDROXYCHLOROQUINE (4,105)
RITUXIMAB (4,067)
INFLIXIMAB (3,784)
TOFACITINIB (3,734)
Which IDURSULFASE Alternatives Have Lower Mobility decreased Risk?
IDURSULFASE vs IFOSFAMIDE
IDURSULFASE vs IGURATIMOD
IDURSULFASE vs ILOPERIDONE
IDURSULFASE vs ILOPROST
IDURSULFASE vs IMATINIB